Number of Chronic Wounds, Ulcers and Diabetic Ulcers
According to NCBI, more than 9.3 percent of United States population which is estimated around 29.1 million people, is affected by diabetes. In adults who are aged over 65 years, the percent of population suffering with diabetes is more than 25 percent. The incidence of chronic wounds especially foot ulcers increases among the diabetic population. While more than 80,000 adults are expected to undergo a lower extremity amputation, It is also estimated that patient with diabetes are 10 times more likely to undergo amputation at some point in their life. The number of diabetes patients are expected to increase with increasing geriatric population which in turn will drive the market for wound care management in the forecast period. In addition, increase in surgical procedures worldwide along with increasing ageing population is also fuelling the growth of wound care management devices market.
High Treatment Costs
Wound care management is associated with high costs due to which it has a low adoption rate. According to a breakdown of wound costs provided by Smith & Nephew, 15-20% are material costs, 30-35% are nurse costs and more than 50% are hospitalization costs. Since, the hospitalization in necessary until the wound is dried, the high hospitalization costs is hindering the advance wound care management market globally. Additionally, lack of reimbursement policies all over the world is also responsible for hindering the growth of market.
North America to Dominate the Market
The Wound Care Management Devices market is segmented by product type, wound type, and geography. By geography it is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and South America. North America dominates the advance wound care management market due to increasing incidences of chronic wounds, favorable reimbursement policies and rise in geriatric population. Europe is also expected to boost the growth of advance wound care management market due to increasing awareness of wound care management among geriatric population. Factors such as increasing accessibility to healthcare facilities in the region, rising medical tourism, and increasing prevalence of chronic diseases are also expected to contribute to the growth of market in this region.
Key Developments in the Market
- December 2017: Smith & Nephew announced European launch of MolecuLight i:X, which is a handheld imaging device that can be used to instantly measure wound surface area and visualize the presence of potentially harmful bacteria in it.
Reasons to Purchase this Report
- Market analysis for the Global Wound Care Management Devices Market, with region-specific assessments and competition analysis on a global and regional scale.
- Analyzing various perspectives of the industry with the help of Porter’s five forces analysis.
- The treatment type that is expected to dominate the market.
- Regions that are expected to witness fastest growth during the forecast period
- Identify the latest developments, market shares and strategies employed by the major market players.
- 3 months analyst support along with the Market Estimate sheet in excel.
This report can be customized to meet your requirements..
1.1 MARKET DEFINITION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. KEY INFERENCES
5. MARKET OVERVIEW
5.1 CURRENT MARKET SCENARIO
5.2 PORTER’S FIVE FORCES
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF CONSUMERS
5.2.3 THREATS OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTE PRODUCT AND SERVICES
5.2.5 COMPETITIVE RIVALRY WITHIN THE INDUSTRY
6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
6.1 MARKET DRIVERS
6.1.1 INCREASING DEMAND FOR FASTER RECOVERY OF WOUNDS
6.1.2 INCREASING INCIDENCES OF CHRONIC WOUND
6.1.3 INCREASE IN SURGERIES
6.1.4 INCREASE IN AGING POPULATION
6.2 MARKET RESTRAINTS
6.2.1 HIGH COST PROCEDURES
6.2.2 LACK OF PROPER REIMBURSEMENTS
6.2.3 RELUCTANCE IN ACCEPTANCE OF NEW TECHNOLOGIES
6.4 KEY CHALLENGES
7. Market Segmentation
7.1 BY PRODUCT
7.1.1 ADVANCED WOUND MANAGEMENT PRODUCTS
184.108.40.206 ADVANCED WOUND DRESSINGS
220.127.116.11.1 FOAM DRESSINGS
18.104.22.168.2 HYDROCOLLOID DRESSINGS
22.214.171.124.3 FILM DRESSINGS
126.96.36.199.4 ALGINATE DRESSINGS
188.8.131.52.5 HYDROGEL DRESSINGS
184.108.40.206.6 OTHER ADVANCED DRESSINGS
220.127.116.11 WOUND THERAPY DEVICES
18.104.22.168.1 PRESSURE RELIEF DEVICES
22.214.171.124.2 NEGATIVE PRESSURE WOUND THERAPY (NPWT) SYSTEMS
126.96.36.199.2.1 CONVENTIONAL NPWT SYSTEMS
188.8.131.52.2.2 DISPOSABLE NPWT SYSTEMS
184.108.40.206.3 OXYGEN AND HYPERBARIC OXYGEN EQUIPMENT
220.127.116.11.4 ELECTRICAL STIMULATION DEVICES
18.104.22.168.5 OTHER THERAPY DEVICES
22.214.171.124 SURGICAL WOUND CARE PRODUCTS
126.96.36.199.1 SUTURES AND STAPLES
188.8.131.52.2 TISSUE ADHESIVES, SEALANTS, & GLUES
7.2 BY END USER
7.2.1 HOSPITALS AND SPECIALTY WOUND CLINICS
7.2.2 LONG-TERM CARE FACILITIES
7.3 BY GEOGRAPHY
7.3.1 NORTH AMERICA
184.108.40.206 REST OF EUROPE
220.127.116.11 SOUTH KOREA
18.104.22.168 REST OF APAC
7.3.4 MIDDLE EAST AND AFRICA
22.214.171.124 SOUTH AFRICA
126.96.36.199 REST OF MIDDLE EAST AND AFRICA
7.3.5 SOUTH AMERICA
188.8.131.52 REST OF SOUTH AMERICA
8. COMPETITIVE LANDSCAPE
8.1 MERGERS AND ACQUISITIONS
8.2 AGREEMENTS, COLLABORATIONS AND PARTNERSHIPS
8.3 NEW PRODUCT LAUNCHES
9. KEY PLAYERS
9.2 KCI OWNED BY ACELITY
9.4 SMITH &NEPHEW
9.9 DERMA SCIENCES
9.10 MOLNLYCKE HEALTH CARE
10. FUTURE OUTLOOK OF THE MARKET